Skip to Content

Acusphere Inc ACUS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ACUS is trading at a 732% premium.
Price
$0.00
Fair Value
$8.36
Uncertainty
Extreme
1-Star Price
$1.96
5-Star Price
Economic Moat
Qfg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACUS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.03 / $0.10
Market Cap
$4.95
Volume/Avg
225 / 527

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
118

Valuation

Metric
ACUS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ACUS
Quick Ratio
0.21
Current Ratio
0.29
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
ACUS
Return on Assets (Normalized)
−105.90%
Return on Equity (Normalized)
−400.58%
Return on Invested Capital (Normalized)
−169.06%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
JmpdplqyvQff$82.1 Bil
Merck KGaA ADR
MKKGY
QdpwtjygDlnss$75.2 Bil
Haleon PLC ADR
HLN
DlxjqybvvGltj$41.4 Bil
Viatris Inc
VTRS
GqmddkqwPcc$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
TrkjwjfGwjb$13.7 Bil
Catalent Inc
CTLT
BphzzqvSnnbd$10.6 Bil
Perrigo Co PLC
PRGO
RymnqpgqsZcm$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
NltkdrsbxTbhyf$3.5 Bil
Curaleaf Holdings Inc
CURLF
CnxbzvhlSzv$3.0 Bil
Green Thumb Industries Inc
GTBIF
HwhcdbrxcXnmr$2.7 Bil

Sponsor Center